what should have been big news for MBX ...... today looks like a complete dud, based on market reaction. McWhirter a couple of months ago on BNN lunch hour show mentioned he's got a $0.70/share target on MBX because they would have a huge opportunity in generating revenues from HPV diagnostic tests. Today MBX announces that they have approval for their HPV tests for the European market, where they are already selling a lot of other product, and so they have the distribution network all set up already. This announcement should have lit a fire under the share price and should have confirmed McWhirter's prognostication. What gives?!